Keyphrases
Cervical Cancer Screening
100%
Clinical Validation
100%
Home Use
100%
Collection Method
100%
Non-randomized Clinical Trial
100%
Self-collection
100%
Self-collected
100%
Percentage Agreement
44%
High-risk Human Papillomavirus (HR-HPV)
33%
Clinical Sensitivity
33%
Paired Samples
22%
Cervical Dysplasia
22%
Self-collected Sample
22%
U.S. Food
11%
Barriers to Screening
11%
Cervical Cancer
11%
US Women
11%
Point Analysis
11%
Healthcare Settings
11%
Clinical Site
11%
Primary Outcome Measure
11%
Clinical Performance
11%
Human Papillomavirus Testing
11%
Relative Sensitivity
11%
Academic Practice
11%
Community Practice
11%
Primary Screening
11%
Method Comparison Study
11%
Home Setting
11%
Preference Survey
11%
PreservCyt
11%
Dry Storage
11%
Home Performance
11%
Dry Transport
11%
Medicine and Dentistry
Clinical Trial
100%
Clinician
100%
Cervical Cancer Screening
100%
Wart Virus
50%
Uterine Cervix Dysplasia
33%
Cervical Screening
33%
Health Care
16%
Cervical Cancer
16%
Primary Outcome
16%
Preference
16%
Nursing and Health Professions
Uterine Cervix Cancer
100%
Food and Drug Administration
100%
Uterine Cervix Dysplasia
100%
Cancer Screening
100%
Health Care
50%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Uterine Cervix Cancer
100%
Human Papillomavirus
100%
Uterine Cervix Dysplasia
66%
Preference
33%